Theravance Biopharma(TBPH) - 2024 Q1 - Earnings Call Transcript

Good afternoon and welcome to Theravance Biopharma's first quarter 2024 earnings results conference call. On Slide 2, you'll find our safe harbor language and I'd remind everyone that are called today will include forwardlooking statements involving risks and uncertainties pertaining to our development pipeline, expected benefits of our product candidate, anticipated timing of clinical trials, regulatory filings, and expected financial results. Information concerning factors that could cause results to diff ...